Dapagliflozin in Type 2 Diabetes Mellitus Patients (T2DM) With Nonalcoholic Fatty Liver Disease (NAFLD)

Clinical trial NCT05459701 · COMPLETED

Trial details

NCT number: NCT05459701
Sponsor: Rehab Werida
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Nonalcoholic Fatty Liver Disease Type 2 Diabetes

Start date: 2022-05-01
Primary completion: 2024-06-30
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.